Therapix Biosciences - 48 Year Dividend Yield History | TRPX

Historical dividend payout and yield for Therapix Biosciences (TRPX) since 1971. The current TTM dividend payout for Therapix Biosciences (TRPX) as of March 25, 2019 is $0.00. The current dividend yield for Therapix Biosciences as of March 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.015B $0.000B
Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.179B 12.96
Gilead Sciences (GILD) United States $81.339B 10.35
Bio-Techne Corp (TECH) United States $7.264B 48.94